Zymeworks (ZYME) Net Margin (QoQ) (2021 - 2026)

Zymeworks (ZYME) Net Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Zymeworks 1.79 Bn 1.52 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 85,316.00
Mar 31, 2026 -19,544.00
Dec 31, 2025 -156,754.00
Sep 30, 2025 -7,574.00
Jun 30, 2025 8,825.00
Mar 31, 2025 -775.00
Dec 31, 2024 11,081.00
Sep 30, 2024 928.00
Jun 30, 2024 11,974.00
Mar 31, 2024 -23,002.00
Dec 31, 2023 8,824.00
Sep 30, 2023 55,674.00
Jun 30, 2023 -66,208.00
Mar 31, 2023 -16,366.00
Dec 31, 2022 191,376.00
Sep 30, 2022 -63,114.00
Jun 30, 2022 260,304.00
Mar 31, 2022 -330,105.00
Dec 31, 2021 88,896.00